DGAP-News: Genetic Immunity Clinical Trial Data Published in PLoS ONE
Genetic Immunity
17.05.2012 16:00
—————————————————————————
DermaVir Immunization Boosted Long-lasting Memory T-cell Responses in Every
Patient
MCLEAN, Va. and BUDAPEST, Hungary, 2012-05-17 16:00 CEST (GLOBE NEWSWIRE) —
Genetic Immunity Inc., a privately-held, biopharmaceutical company developing
Langerhans cell-targeted immunotherapies, published its human proof-of-concept
clinical trial, in PLoS ONE, a highly-regarded medical industry pub
